Drug trial at Westchester Medical Center puts NYMC among top researchers in the nation racing to find an effective treatment to fight COVID-19
When COVID-19 first hit our shores in early March with no vaccine nor proven drug treatment in sight, new innovative collaborations sprouted up across the nation, as leading research institutions, pharmaceutical companies and hospitals joined forces to find a solution fast. Among them—a collaborative clinical drug trial by New York Medical College (NYMC) and Regeneron launched at Westchester Medical Center (WMC) within the first few weeks. Seeking a partner with whom to establish a clinical drug trial that could be used to treat critically ill patients with COVID-19, Regeneron Pharmaceuticals proposed the collaboration—not only for NYMC’s state-of-the-art virology labs and internationally regarded experts—but because of the College’s decades-long involvement in the annual development of the influenza vaccine.
New York Medical College comes together to support #GivingTuesdayNow on Tuesday, May 5.
The event welcomed keynote speaker Sari J. Siegel, Ph.D.
GSBMS student making the most of her knowledge, skills and aspirations during the COVID-19 pandemic.
The New York Iota chapter of Alpha Omega Alpha (AOA), the national medical honor society, will host its annual visiting professor lecture via Zoom on April 27 at 4:00 p.m.
The New York Medical College community will gather virtually to commemorate Yom Hashoah, Holocaust Remembrance Day, on Monday, April 20, at 5:00 p.m. via a Zoom meeting.
The type of prolonged stress that people are experiencing with the COVID-19 crisis shifts their nervous systems into a state of sympathetic nervous system dominance.
NYMC on Twitter